U.S. Pharma Stock News

If you are wondering whether Ormat Technologies' current share price lines up with its underlying value, this article will walk you through the numbers in a straightforward way. The stock closed at US$110.38, with returns of 1.4% over 7 days, a 10.4% decline over 30 days, a 2.9% decline year to date, and a 54.4% return over 1 year, alongside 3 year and 5 year returns of 39.8% and 49.7% respectively. Recent coverage has focused on Ormat Technologies as a long standing player in the US...

If you are wondering whether Delta Air Lines is priced attractively right now, this article walks through what the current share price might imply about its underlying value. The stock last closed at US$58.78, with a 7 day return of 0.4% decline, a 30 day return of 17.7% decline, a year to date return of 14.9% decline, a 1 year return of 27.3%, and a 3 year return of 83.8%. Recent coverage around Delta has focused on how investors are reassessing major US airlines as a group, including...

Ardelyx recently reported the peer-reviewed publication of pooled clinical data showing its IBSRELA (tenapanor) therapy delivered earlier and sustained symptom relief in adults with IBS-C, with no new safety concerns identified. The analysis offers clinicians practical guidance on treatment duration and symptom timelines, potentially influencing how IBSRELA is positioned and used in everyday care. We’ll now examine how this new evidence of earlier and sustained IBS-C symptom relief could...

Zacks Equity Research recently highlighted Spire Inc.’s long-term infrastructure and innovation plans, including an expected US$11.20 billion in capital investments over the next decade, alongside its current 3.59% dividend yield and analyst estimates for long-term earnings growth. The analysis underscores how these planned investments and anticipated earnings expansion could influence Spire’s role in a gas utility sector balancing aging infrastructure, renewable competition, and the...

McEwen (MUX) closed out FY 2025 with Q4 revenue of US$64.6 million and basic EPS of US$0.70, alongside net income of US$38.1 million, putting a clear marker on its latest financial run rate. Over the year, quarterly revenue ranged from US$35.7 million in Q1 to US$64.6 million in Q4, while basic EPS moved between a loss of US$0.12 and a gain of US$0.70, giving investors a wide view of how profitability has tracked against the top line. Overall, the results point to firmer margins in the latest...

Clarivate (NYSE:CLVT) has integrated its regulatory intelligence with Anthropic's Claude AI assistant. The collaboration embeds Clarivate's regulatory data directly into biopharma, biotech, and medtech AI workflows. The move is aimed at supporting regulatory affairs teams by keeping trusted data closer to day to day decision making. Clarivate focuses on data, analytics, and workflow tools for research driven industries, and life sciences is a core part of that mix. By plugging its...

Hemisphere GNSS, a brand of CNH Industrial, has introduced the A65 GNSS antenna in partnership with Calian Group, targeting better interference rejection and easier upgrades for precision agriculture systems. Forrester Farm Equipment is acquiring AG-Industrial, expanding the CNH dealer network and deepening cooperation on parts and service support across North America. CNH Industrial (NYSE:CNH), trading at about $10.65, has a mixed recent performance, with a 13.9% return year to date but...

If you are wondering whether Toll Brothers is still reasonably priced after a strong run, you are not alone. The stock’s current valuation is a key question for many investors right now. The share price closed at US$136.69, with a 7.4% decline over the last 7 days and a 15.3% decline over the last 30 days, while the 1 year return sits at 31.4% and the 3 year and 5 year returns are 143.5% and 165.4% respectively. Recent news flow around Toll Brothers has focused on broader housing market...

In March 2026, Wyndham Hotels & Resorts increased its quarterly dividend to US$0.43 per share, appointed Amit Sripathi as Chief Financial Officer, promoted David Wilner to Chief Development Officer – North America, and was selected by ALMAL Real Estate Development to manage a new luxury Registry Collection hotel in Bali’s Nusa Dua enclave. Together, the higher dividend, leadership changes and expansion into upscale international projects highlight Wyndham’s focus on fee-based growth, capital...

Kalshi recently announced a partnership with Brazilian broker XP Inc. to offer regulated prediction markets to XP clients holding international investment accounts, initially via the Clear Corretora platform and focused on financial and economic event-based contracts. This move introduces a new asset class alongside equities, ETFs, bonds, and derivatives on XP’s international platform, underscoring XP’s push to broaden product diversification and financial innovation for Brazilian investors...

In the past week, Ingram Micro Holding Corporation completed a US$200.00 million follow-on equity offering of 8,988,764 common shares at US$22.25 each, while also announcing a new US$100.00 million share repurchase program tied to secondary offerings by existing shareholders. This combination of fresh equity issuance, a major sell-down by Platinum Equity LLC, and a buyback authorization highlights a significant reshaping of Ingram Micro’s shareholder base without directly changing its...

Infrastructure build out becomes the key story for Atmos Energy Atmos Energy (ATO) is ramping up its infrastructure program, with US$3.6b allocated in fiscal 2025 and a planned US$4.2b in 2026, supported by lower interest rates that ease financing costs. See our latest analysis for Atmos Energy. The stock’s recent move appears to reflect investors reacting to this heavier infrastructure spend, with a 7.17% 1 month share price return and a 28.61% 1 year total shareholder return suggesting...

Why Axsome’s Latest Legal and Regulatory Headlines Matter for Shareholders Axsome Therapeutics (AXSM) is back in focus as investors weigh a new shareholder investigation into past AXS-07 regulatory disclosures, alongside an upcoming FDA decision on AXS-05 for Alzheimer’s disease agitation. See our latest analysis for Axsome Therapeutics. At a share price of $156.08, Axsome’s 1 day share price return of 1.27% and 90 day share price return of 5.34% contrast with a 30 day share price return of a...

First Beijing Investment Ltd has become a major shareholder in Luckin Coffee (OTCPK:LKNC.Y) after acquiring over 107,000,000 shares. The purchase gives First Beijing Investment Ltd control of more than 5% of the company, crossing the threshold for a significant ownership stake. This change in the shareholder base introduces a new institutional holder that could influence future discussions around governance and strategy. Luckin Coffee operates a large coffee chain footprint in China,...

DENTSPLY SIRONA (NasdaqGS:XRAY) and Siemens Healthineers secured FDA clearance for the MAGNETOM Free.Max Dental Edition, described as the first MRI system dedicated to dental use. The company is preparing for a US launch, supported by clinical trial data and upcoming training programs for dental professionals. The system is designed to offer high contrast, non ionizing imaging for applications such as endodontics and TMJ assessment. At a current share price of $11.54, DENTSPLY SIRONA comes...

If you are wondering whether Hinge Health is attractively priced or already baking in a lot of optimism, this article is designed to help you frame that question clearly. The stock last closed at US$45.00, with a 16.1% gain over the past 30 days, but a 2.5% decline over the last week and a 1.2% decline year to date. This hints at shifting views on both its potential and its risks. Recent news coverage has focused on Hinge Health's position as a listed musculoskeletal care company, along with...

In March 2026, Tandem Diabetes Care announced that its FDA-cleared Tandem Mobi mobile app is now available to U.S. Android users via Google Play, enabling direct control of the Tandem Mobi automated insulin delivery system from select Google Pixel 6–10 and Samsung Galaxy S21–S25 smartphones. This expansion to Android significantly broadens the pool of potential users who can integrate Tandem Mobi into their existing devices, strengthening the appeal of Tandem’s connected diabetes management...

If you are wondering whether Copa Holdings at around US$110 per share is offering good value right now, looking closely at how it is priced versus its fundamentals can help you frame that decision. The stock has had a mixed run, with a 25.5% return over the last year and a 52.9% return over three years, alongside shorter term moves such as a 26.7% decline over the last 30 days and an 11.7% decline over the past week. Recent news around Copa Holdings has focused on its position in Latin...

NASA awarded Redwire (NYSE: RDW) an additional US$4 million for drug development research on the International Space Station. The funding supports Redwire's Pharmaceutical In-space Laboratory, known as PIL-BOX, expanding its existing contract with NASA. The project focuses on using microgravity to study and manufacture potential future pharmaceutical treatments. For investors watching the space infrastructure theme, Redwire sits at the intersection of space hardware and applied research,...

Wondering whether Gibraltar Industries is starting to look like value at today’s price, or if the stock’s risks still outweigh the potential upside? This article is built to help you weigh that up using clear valuation checks. After closing at US$41.27, the stock has seen a 2.6% gain over the last 7 days. That sits against a 23.7% decline over 30 days and a 36.9% decline over the past year, with returns of 17.7% decline year to date, 11.2% decline over 3 years and 52.7% decline over 5...

ServiceTitan (TTAN) just posted another quarter of rapid top line expansion, with Q3 FY 2026 revenue at US$249.2 million and a basic EPS loss of US$0.42, against a backdrop of 26.5% revenue growth over the past year and a trailing twelve month net loss of US$298.1 million. The company has seen quarterly revenue move from US$192.9 million in Q2 FY 2025 to US$249.2 million in Q3 FY 2026. Over the same period, basic EPS losses ranged from US$1.43 in Q2 FY 2025 to US$0.42 in the latest quarter,...

In recent commentary, billionaire investor Mario Gabelli and other analysts highlighted Bank of New York Mellon Corporation’s exposure to a steeper interest-rate curve, stronger deal activity, supportive equity markets, and spending by affluent clients as key business tailwinds. Analysts also emphasized BNY’s capital-light model and long-standing, “sticky” client relationships, suggesting these structural features may underpin confidence in its earnings quality and competitive...

In recent days, Hershey has expanded its product lineup, rolling out Dot’s Original Snack Mix nationwide in multiple bag sizes and launching limited-edition vanilla, lime and coconut Twizzlers Straws inspired by the Dirty Soda trend through online channels and select Hershey’s Chocolate World locations. These launches highlight how Hershey is leaning on innovation in both salty snacks and confectionery to reinforce brand relevance and capture shifting consumer snacking habits. We’ll now...

Green Brick Partners, through its Trophy Signature Homes subsidiary, recently opened the Lone Oak master-planned community in Alvarado, Texas, while also continuing to expand its land pipeline and community count across key Texas markets to serve first-time and move-up buyers. This combination of new community launches and a broadened buyer mix adds another layer of execution risk but also enhances the company’s potential to smooth revenue across housing cycles. We’ll now explore how the...